CDMO: EUROAPI Supports Sanofi's mRNA Vaccine Platform with the Development of Lipid Nanoparticles
EUROAPI is a global leader in lipid nanoparticles with strong expertise in its Budapest and Frankfurt Development, Pilot and Manufacturing sites Sanofi decided to expand its collaboration
Source: finanznachrichten.de